2006
DOI: 10.1177/1721727x0600400301
|View full text |Cite
|
Sign up to set email alerts
|

Glaucoma: Current and Developing Concepts for Inflammation, Pathogenesis and Treatment

Abstract: Glaucoma is a prevalent neurodegenerative disorder of the eye. However, the mechanism leading to the disease is still unclear. Increased intraocular pressure (lOP) and subsequent retinal ganglion cell (RGC) death leading to the loss of visual field characterizes the pathology of primary open angle glaucoma, which is the most common form. Possible factors leading to glaucoma include glutamateinduced neurotoxicity, nitric oxide (NO) based damage, disruption of neurotrophic factor transport and immune-induced neu… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
18
0
1

Year Published

2010
2010
2022
2022

Publication Types

Select...
6
4

Relationship

0
10

Authors

Journals

citations
Cited by 23 publications
(19 citation statements)
references
References 38 publications
0
18
0
1
Order By: Relevance
“…Glaucoma is second leading cause of blindness worldwide. 1 Characterized by progressive degeneration of retinal ganglion cells and optic nerve fibers, leading to gradual deterioration of visual field. If untreated, it can lead to irreversible blindness.…”
Section: Introductionmentioning
confidence: 99%
“…Glaucoma is second leading cause of blindness worldwide. 1 Characterized by progressive degeneration of retinal ganglion cells and optic nerve fibers, leading to gradual deterioration of visual field. If untreated, it can lead to irreversible blindness.…”
Section: Introductionmentioning
confidence: 99%
“…Glaucoma is the second leading cause of blindness worldwide 1 . It affects 60 million people globally and is responsible for 12% of global blindness.…”
Section: Introductionmentioning
confidence: 99%
“…[1][2][3] Glaucoma is characterized by slow progressive degeneration of the retinal ganglion cells (RGCs) and the optic nerve axons, leading to increase in deterioration of the visual field. [3][4][5][6] For treatment of glaucoma in this study we use timolol maleate as drug in combination with various different polymers (xanthan gum, gellan gum,carbopol 974P to enhance the bioavailabilty of drug [7][8][9][10] .Recently, much research has been dedicated to mucoadhesive polymers i.e. macromolecules capable of retaining the medication in the precorneal area not only by viscosity effects, but also by establishing physicochemical interactions with the mucin layer covering the corneal epithelium.…”
Section: Introductionmentioning
confidence: 99%